Nature , 508(7495), 258262
Response: We disagree with the commenter's interpretation that these diagnostic radiopharmaceuticals would remain policy-packaged under 42 CFR 419.2(b)(15) after we implemented the CY 2025 diagnostic radiopharmaceuticals separate payment policy (89 FR 93948)
It also shows an enhancement in physical performance, While this evidence is very promising, its still early in the research process
This guide breaks down everything the research says, what BPC-157 is, how it works in the body, what the studies show, dosing protocols people use, side effects to watch for, and whether it makes sense for you
Brenchley and Douek 2012)
It's really about what your body needs and what your healthcare provider recommends